Mochida Pharmaceutical Co.,Ltd.JP:4534Income statement

Market cap
¥131.5B
P/E ratio
23.7x
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Revenue86,20589,21093,94787,25292,27297,349106,761109,643101,799102,995110,179103,261102,885105,159
Cost of revenue---33,91337,27341,04353,18255,47749,88248,20350,62648,14650,81551,371
Gross profit---53,33954,99856,30653,57854,16651,91754,79159,55355,11452,07053,787
Gross margin (%)---
Operating income ---11,68912,15411,37411,66210,5908,80712,00314,3928,5075,8028,126
Operating expenses ---41,65842,84544,93641,90443,58443,11242,78845,16146,60746,26745,661
Income before tax 15,28614,18816,79911,90912,39211,64812,00810,9289,15412,26014,7999,0856,0378,067
Provision for income taxes---3,5973,9463,0573,0923,2071,6753,3124,0222,3951,6132,367
Net income 7,7858,4189,4557,5448,1508,5269,0238,4354,5988,58710,5696,6494,5475,685
Earnings per share430.46442.26488.66377.27410.46429.46454.55212.87117.56222.29277.39178.93126.8160.36
Dividend per share2627106150150155170170809090808080